MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity-Reference-Cited by-同舟云学术

MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity

Published:2022-03-09 Issue:9 Volume:42 Page:1477-1490
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J of Applied Toxicology

Author:

Desai Varsha G.¹^ORCID,Vijay Vikrant¹,Lee Taewon²,Han Tao¹,Moland Carrie L.¹,Phanavanh Bounleut¹,Herman Eugene H.³,Stine Kimo⁴,Fuscoe James C.¹

Affiliation:

1. Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research U.S. Food and Drug Administration Jefferson Arkansas USA

2. Division of Applied Mathematical Sciences Korea University Sejong Korea

3. Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis The National Cancer Institute Rockville Maryland USA

4. Department of Pediatrics, Pediatric Hematology‐Oncology Arkansas Children's Hospital Little Rock Arkansas USA

Publisher

Wiley

Subject

Toxicology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jat.4309

Reference59 articles.

1. Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress

2. Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors

3. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404

4. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

5. Cardiomyopathy Prevention in Cancer Patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of autophagy-related signatures in doxorubicin-induced cardiotoxicity;Toxicology and Applied Pharmacology;2024-10

2. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

3. Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma;International Journal of Molecular Sciences;2024-07-16

4. Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity;JACC: CardioOncology;2024-04

5. Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway;Biomedicine & Pharmacotherapy;2023-12